GlassScriptPhysician profile
Eric Joseph Hammond
NPI 1679011993
$19,977.14
in general payments reported to CMS, 2019-2025
22 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $5,662 · 2021: $482 · 2022: $769 · 2023: $480 · 2024: $387 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,095 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,095.43 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $15,255.41 | 2019-2020 | |
| Coopervision INC. | $2,427.30 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $490.86 | 2019-2025 | |
| Lkc Technologies, INC. | $335.37 | 2022-2024 | |
| Alcon Vision LLC | $268.19 | 2019-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $228.71 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $212.75 | 2019-2021 | |
| Allergan, INC. | $135.48 | 2019-2022 | |
| Abb Con-Cise Optical Group LLC | $118.16 | 2021-2023 | Contact Lens, Spectacle Lenses |
| Horizon Therapeutics Plc | $108.68 | 2022 | |
| Oyster Point Pharma, INC. | $60.33 | 2022-2025 | Tyrvaya |
| Abbvie INC. | $53.88 | 2022-2023 | |
| Kala Pharmaceuticals, INC. | $43.20 | 2021-2022 | |
| Visioneering Technologies, INC. | $43.00 | 2019-2021 | |
| Optos, INC. | $33.72 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $32.96 | 2019 | |
| Rxsight INC | $25.67 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $24.51 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $23.40 | 2024 | Xdemvy |
| Harrow Eye, LLC | $21.63 | 2024 | Vevye |
| Dompe US, INC. | $17.34 | 2021 | |
| Lombart Brothers, INC. | $16.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hammond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.